Ready, Set, Cut: Bristol Headcount Reductions Imminent
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug maker will release details on its productivity initiative during an investor meeting Dec. 5.
You may also be interested in...
Bristol Restructures To Cut Costs, Transform Into Next-Generation Biopharma
Plan to achieve $1.5 billion in cost reductions by 2010 includes a 10 percent net reduction in head count.
Bristol Restructures To Cut Costs, Transform Into Next-Generation Biopharma
Plan to achieve $1.5 billion in cost reductions by 2010 includes a 10 percent net reduction in head count.
Novartis Cuts Over 1,200 U.S. Pharma Jobs
Reorganization will save $230 million in 2008, firm says in third quarter earnings report.